YVETTE MIGNON: Open Payments
NPI 1689743288 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 32 payments from 13 companies in 2025. Trend: 2023 $1,320 · 2024 $1,064 · 2025 $632
Food & beverage: $632
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $207 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $69 |
| Indivior Inc. | 2 | $53 |
| Lilly USA, LLC | 3 | $53 |
| Blueprint Medicines Corporation | 1 | $39 |
| Exact Sciences Corporation | 2 | $38 |
| GENZYME CORPORATION | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Novo Nordisk Inc | 2 | $28 |
| BETA BIONICS, INC. | 1 | $25 |
Products named: UBRELVY, AYVAKIT, CAPLYTA, QULIPTA, SUBLOCADE, VRAYLAR, MOUNJARO, The Cologuard Plus Collection Kit.
Industry payments across FL — which companies pay providers there.
